Retatrutide ELISA Kit

Retatrutide ELISA Kit: A Comprehensive Tool for

Therapeutic Target Identification and Research Use

The Retatrutide ELISA Kit is a highly advanced and reliable tool for the detection and quantification of Retatrutide, a novel therapeutic target in the field of cancer research. This enzyme-linked immunosorbent assay (ELISA) kit provides a highly sensitive and specific method for the measurement of Retatrutide levels in various biological samples, making it an essential tool for both basic research and clinical applications.

Structure of Retatrutide

Retatrutide, also known as C7orf24, is a protein that is encoded by the C7orf24 gene located on chromosome 7. It is a 24 kDa protein that consists of 211 amino acids and contains a signal peptide at the N-terminus. The protein has a transmembrane domain and a cytoplasmic domain, making it a type I transmembrane protein. Retatrutide is highly expressed in various cancer cells and has been identified as a potential therapeutic target for the treatment of cancer.

Activity of Retatrutide

Retatrutide has been shown to play a key role in the regulation of cell proliferation, migration, and invasion in cancer cells. It is believed to act as a tumor suppressor by inhibiting the growth and spread of cancer cells. Studies have also shown that Retatrutide interacts with various signaling pathways, such as the PI3K/Akt and MAPK pathways, to regulate cell survival and apoptosis. Additionally, Retatrutide has been found to modulate the expression of various genes involved in cancer progression, making it a promising therapeutic target for cancer treatment.

Application of Retatrutide ELISA Kit

The Retatrutide ELISA Kit is a powerful tool for the detection and quantification of Retatrutide in various biological samples, including serum, plasma, and tissue lysates. It provides a simple, fast, and accurate method for the measurement of Retatrutide levels, making it an essential tool for both basic research and clinical applications. The kit is highly sensitive, with a detection limit of 0.1 ng/ml, and has a wide dynamic range of 0.5-100 ng/ml, allowing for the measurement of both low and high levels of Retatrutide in samples.

One of the key applications of the Retatrutide ELISA Kit is in the identification of potential therapeutic targets for cancer treatment. By measuring the levels of Retatrutide in different cancer cell lines and tissues, researchers can identify the role of this protein in cancer progression and its potential as a therapeutic target. The kit can also be used to monitor the effectiveness of cancer treatments by measuring changes in Retatrutide levels before and after treatment.

Furthermore, the Retatrutide ELISA Kit can also be used in drug discovery and development. By measuring the levels of Retatrutide in response to various compounds, researchers can identify potential drug candidates that can modulate the activity of this protein and potentially be used in the treatment of cancer.

Conclusion

The Retatrutide ELISA Kit is a powerful and versatile tool for the detection and quantification of Retatrutide, a promising therapeutic target in cancer research. Its high sensitivity, accuracy, and wide dynamic range make it an essential tool for both basic research and clinical applications. With the increasing interest in Retatrutide as a potential therapeutic target, this ELISA kit is expected to play a crucial role in advancing cancer research and drug development.